Browse > Article

TARGETING RECEPTOR TYROSINE KINASE ON ENDOTHELIAL CELLS IN AN ORTHOTOPIC TUMOR MODEL OF ORAL SQUAMOUS CELL CARCINORMA  

Park, Young-Wook (Department of Oral & Maxillofacial Surgery, College of Dentistry, Kangnungwonju National University)
Kim, So-Hee (Department of Pharmacology, College of Dentistry, Kangnungwonju National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.35, no.2, 2009 , pp. 55-65 More about this Journal
Abstract
Purpose: We determined the therapeutic effects of blockade of epidermal growth factor(EGF) and vascular endothelial growth factor(VEGF) receptor tyrosine kinases on the growth of oral squamous cell carcinoma(OSCC) xenografted in athymic nude mice. Experimental Design: We investigated the in vivo antitumor effects of a tyrosine kinase inhibitor for EGFR and VEGFR-2, AEE788 in a mouth floor(orthotopic) tumor model. Nude mice with orthotopic tumors were randomized to receive AEE788, paclitaxel, a combination of AEE788 and paclitaxel, or control. Antitumor mechanisms of AEE788 were determined by immunohistochemical/immunofluorescent and apoptosis assays. Results: Tumors of mice treated with AEE788 demonstrated down-regulation of phosphorylated EGFR, phosphorylated VEGFR and their downstream mediators(pMAPK and pAkt), decreased proliferative index, decreased microvessel density(MVD). As a result, growth of the primary tumor and nodal metastatic potentials were inhibited by AEE788. Conclusion: These data show that EGFR and VEGFR can be molecular targets for the treatment of OSCC.
Keywords
Oral squamous cell carcinoma; Epidermal growth factor receptor; Vascular endothelial growth factor receptor; Nodal metastatic potential;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Maekawa T, Ashihara E, Kimura S: The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias. Int J Clin Oncol 2007; 12(5): 327-340   DOI   PUBMED   ScienceOn
2 Park YW, Lee JW, Kim SH: Expressions of metastasis-related factors in orthotopic tumor models of oral squamous cell carcinoma. J Kor Assoc Maxillofac Plast Reconstr Surgeons 2008; 30(6): 529-539   과학기술학회마을
3 Yu C, Friday BB, Lai JP, Mccollum A, Atadja P, Roberts LR et al: Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation. Clin cancer res 2007; 13(4): 1140-1148   DOI   PUBMED   ScienceOn
4 Sasaki T, Kitadai Y, Nakamura T, Kim JS, Tsan RZ, Kuwai T et al: Inhibition if epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice. Neoplasia 2007; 9(12): 1066-1077   DOI   ScienceOn
5 Verheul HMW, Hammers H, Erp KV, Wei Y, Sanni T, Salumbides B et al: Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model. Clin cancer res 2007; 13(14): 4201-4208   DOI   ScienceOn
6 Laakkonen P, Waltari M, Holopainen T, Takahashi T, pytowski B, Steiner P et al: Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer res 2007; 67(2): 593-599   DOI   PUBMED   ScienceOn
7 Dumont DJ, Jussila L, Taipale J: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998; 282: 946-949   DOI   PUBMED   ScienceOn
8 Sano D, Myers JN: Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645-662   DOI   PUBMED
9 Schiff BA, Mcmurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG et al: Epidermal frowth factor receptor(EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin cancer res 2004; 10(24): 8594-602   DOI   PUBMED   ScienceOn
10 Yokoi K, Thaker PH, Yazici S, Rebhun RR, Nam DH, He J et al: Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Cancer res 2005; 65(9); 3716- 3725   DOI   PUBMED   ScienceOn
11 Younes MN, Yigitbasi OG, Park YW, Kim SJ, Jasser SA, Hawthorne VS et al : Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation. Cancer Res 2005; 65: 4716-4727   DOI   ScienceOn
12 Rebhun RB, Langley RR, Yokoi K, Fan D, Gershenwald JE, Fidler IJ: Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. Neoplasia 2006; 8(9): 747-757   DOI   PUBMED
13 Park YW: Targeted molecular therapy in a murine model of oral squamous cell carcinoma with an epidermal growth factor receptor inhibitor. J Kor Assoc Maxillofac Plast Reconstr Surgeons 2009; 31(1): 8-17   과학기술학회마을   PUBMED
14 Roberts N, Kloos B, Cassella M, Podgrabinska S, persuad K, Wu Y et al: Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer res 2006; 66(5): 2650-2657   DOI   ScienceOn
15 Wang D, Stockard CR, Harkins L, Lott P, Salih C, Yuan K et al: Immunohistochimistry for the evaluation of angiogenesis in tumor xenografts. Biotech Histochem 2008; 83(3): 179-189   DOI   PUBMED   ScienceOn
16 Choi S, Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008; 87(1): 14-32   DOI   PUBMED   ScienceOn
17 Kupferman ME, Myers JN: Molecular biology of oral cavity squamous cell carcinoma. Otolaryngol Clin North Am 2006 ; 39(2): 229-247   DOI   PUBMED   ScienceOn
18 Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P et al: Expression of the epidermal growth factor receptor( EGFR) and the phosphorylated EGFR in invasive breast carcinomas. Breast cnacer research 2008; 10(3): 1-8   DOI   PUBMED
19 Lopez-Albaitero A, Ferris RL: Immune activation by epidermal growth factor receptor-specific monoclonal antibody therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg 2007; 133(12): 1277-1281   DOI   ScienceOn
20 He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S et al: Vascular endothelial growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005; 65(11): 4739-4746   DOI   PUBMED   ScienceOn
21 Yazici S, Kim SJ, Busby JE, He J, Thaker PH, Yokoi K et al: Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice. Prostate 2005; 65(3): 203-215   DOI   PUBMED   ScienceOn
22 Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D et al: AEE788 : A dual family epidermal growth factor receptor/ ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res 2004; 64: 4931-4941   DOI   PUBMED   ScienceOn
23 Park YW, Younes MN, Jasser SA, Yigitbasi OG, Zhou G, Bucana CD et al: AEE788, a dual tyrosine kinase inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice. Clin Cancer Res 2005; 11: 1963-1973   DOI   PUBMED   ScienceOn
24 Yigitbasi OG, Younes MN, Doan D, Jasser SA, Schiff BA, Bucana CD et al : Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 2004; 64: 7977-7984   DOI   PUBMED   ScienceOn
25 Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fans D, Villares GJ et al: Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia 2008; 10(5): 489-500   DOI   PUBMED
26 Yokoi K, Kim SJ, Thaker P, Yazici S, Man DH, He J et al: Induction of apoptosis on tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice. Neoplasia 2005; 7(7): 696-704   DOI   PUBMED   ScienceOn